Steven Herman
Family Medicine · Hamburg, NYNPI 1447214903
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 26.0% of the total.
Across 126 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$597
- Novo Nordisk$358
- Lilly USA, LLC$323
- GSK$314
- Amgen$106
- Pfizer$96
- plus $504 from 13 others
What the payments were for
- Food & beverage$2,299100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $597 |
| Novo Nordisk | 20 | $358 |
| Lilly USA, LLC | 21 | $323 |
| GSK | 12 | $314 |
| Amgen | 7 | $106 |
| Pfizer | 5 | $96 |
| Amarin Pharma, Inc. | 6 | $87 |
| Daiichi Sankyo Inc. | 4 | $67 |
| Optinose US, Inc. | 3 | $59 |
| AbbVie | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 2 | $48 |
| Braintree Laboratories, Inc. | 2 | $44 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Upsher-smith Laboratories LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Neuronetics, Inc. | 1 | $11 |
How this compares
$2,299 in reported general payments places this provider in the 75th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 18 | $468 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hamburg
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
- James NorthGlens Falls$186K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.